Compound class:
Synthetic organic
Comment: AZ1 is a sulfonyl piperazine compound with antibacterial activity, discovered using a high-throughput phenotypic screen [3]. It is a novel inhibitor of bacterial cell wall synthesis that acts by targeting UDP-2,3-diacylglucosamine hydrolase (LpxH), an enzyme in the lipopolysaccharide synthesis pathway [1]. LpxH is an essential enzyme, conserved in the majority of Gram-negative bacteria but absent in human, and an attractive target for antibacterial development.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
1-[5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]sulfonyl-2,3-dihydroindol-1-yl]ethanone |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
AZ1 |
Other databases | |
CAS Registry No. | 901260-40-0 (source: Scifinder) |
GtoPdb PubChem SID | 496703318 |
PubChem CID | 16002750 |
RCSB PDB Ligand | OKV |
Search Google for chemical match using the InChIKey | JRTCXCIMCOKGMN-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | JRTCXCIMCOKGMN |
UniChem Compound Search for chemical match using the InChIKey | JRTCXCIMCOKGMN-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | JRTCXCIMCOKGMN-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
LpxH-IN-AZ1 (links to external site)
Cat. No. HY-130836 |